tiprankstipranks
Trending News
More News >
MaxCyte Inc (MXCT)
NASDAQ:MXCT
US Market
Advertisement

MaxCyte (MXCT) Technical Analysis

Compare
76 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
MaxCyte Inc’s (MXCT) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting MaxCyte Inc is a Buy.
MaxCyte Inc’s (MXCT) 20-Day exponential moving average is 2.17, while MaxCyte Inc’s (MXCT) share price is $2.04, making it a Sell.
MaxCyte Inc’s (MXCT) 50-Day exponential moving average is 2.27, while MaxCyte Inc’s (MXCT) share price is $2.04, making it a Sell.

MaxCyte (MXCT) Pivot Points

Aug 05, 2025, 06:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.94
1.98
2.02
2.06
2.10
2.14
2.18
Fibonacci
1.98
2.01
2.03
2.06
2.09
2.11
2.14
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MaxCyte (MXCT) Moving Averages

Aug 05, 2025, 06:20 AM
Period
Simple
Exponential
MA5
2.12Sell
2.10Sell
MA10
2.18Sell
2.14Sell
MA20
2.18Sell
2.17Sell
MA50
2.21Sell
2.27Sell
MA100
2.47Sell
2.55Sell
MA200
3.23Sell
3.10Sell
MaxCyte Inc’s (MXCT) 10-Day exponential moving average is 2.14, while MaxCyte Inc’s (MXCT) share price is $2.04, making it a Sell.
MaxCyte Inc’s (MXCT) 100-Day exponential moving average is 2.55, while MaxCyte Inc’s (MXCT) share price is $2.04, making it a Sell.
MaxCyte Inc’s (MXCT) stock price is $2.04 and MaxCyte Inc’s (MXCT) 50-day simple moving average is 2.21, creating a Sell signal.
MaxCyte Inc’s (MXCT) stock price is $2.04 and MaxCyte Inc’s (MXCT) 100-day simple moving average is 2.47, creating a Sell signal.
MaxCyte Inc’s (MXCT) stock price is $2.04 and MaxCyte Inc’s (MXCT) 200-day simple moving average is 3.23, creating a Sell signal.

MaxCyte (MXCT) Technical Indicators

Aug 05, 2025, 06:20 AM
Name
Value
Implied Action
RSI (14)
40.39
Neutral
STOCH (9,6)
18.55
Buy
STOCHRSI (14)
18.55
Buy
MACD (12,26)
-0.03
Buy
ADX (14)
15.76
Buy
Williams %R
-81.48
Buy
CCI (14)
-157.27
Buy
ATR (14)
0.11
-
Ultimate Oscillator
39.65
Neutral
ROC
-8.93
Sell
MaxCyte Inc’s (MXCT) Relative Strength Index (RSI) is 40.39, creating a Neutral signal.
MaxCyte Inc’s (MXCT) Trend Strength Indicator (ADX) is 15.76, creating a Buy signal.
MaxCyte Inc’s (MXCT) Commodity Channel Index (CCI) is -157.27, creating a Buy signal.
MaxCyte Inc’s (MXCT) Price Rate of Change (ROC) is -8.93, creating a Sell signal.

FAQ

Is MXCT a Buy, Hold, or Sell?
Based on MXCT’s technical indicators, MXCT is a Sell.
    What is MXCT’s RSI (14)?
    MXCT’s RSI (14) is 40.39, which suggests MXCT is a Neutral.
      What is MXCT’s MACD?
      MXCT’s MACD is -0.03, which suggests MXCT is a Buy.
        What is MXCT’s 5-day moving average?
        MXCT’s 5-day moving average is 2.12, which suggests MXCT is a Sell.
          What is MXCT’s 20-day moving average?
          MXCT 20-day moving average is 2.18, which suggests MXCT is a Sell.
            What is MXCT’s 50-day moving average?
            MXCT’s 50-day moving average is 2.21, which suggests MXCT is a Sell.
              What is MXCT’s 200-day moving average?
              MXCT’s 200-day moving average is 3.23, which suggests MXCT is a Sell.
                What is MXCT’s Williams % R (14)?
                MXCT’s Williams % R (14) is -81.48, which suggests MXCT is a Buy.
                  What is MXCT’s CCI (14)?
                  MXCT’s CCI (14) is -157.27, which suggests MXCT is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis